MJ Belman, WC Botnick and JW Shin
Division of Pulmonary Medicine, Cedars Sinai Medical Center, Los Angeles, California 90048, USA.

Dynamic hyperinflation (DH) is a major pathophysiologic consequence of airflow limitation during exercise in patients with chronic obstructive pulmonary disease (COPD) and an important contributing factor to breathlessness. In this study we aimed to examine the effect of inhaled beta agonist therapy on DH during exercise in these patients and the relationship between changes in DH and breathlessness. In 13 COPD patients (mean age 65.1 +/- 2.0, FEV1 1.20 +/- 0.17, FEV1/FVC 40 +/- 3) we measured pulmonary function tests, exercise breathlessness by Borg score, and exercise flow volume and pressure volume loops on two separate days. Prior to testing, patients randomly received inhaled placebo or albuterol on the first test day and the alternative medication on the second test day. From measurements of exercise inspiratory capacity (IC), we calculated the end-expiratory and end- inspiratory lung volumes (EELV, EILV). We used esophageal pressure recordings to measure peak inspiratory esophageal pressure (Pesins) during exercise and this was related to the maximal capacity for pressure generation taking into account lung volume and airflow changes (Pcapi). Bronchodilator caused significant increase in both FEV1 and FVC (+0.23 and +0.51, p<0.01). Comparisons of breathlessness, exercise volumes, and pressures were made at the highest equivalent work load. There was a significant reduction in the peak exercise EELV/TLC (80 +/- 0.02% to 76 +/- 0.02%, p<0.05) while the peak EILV/TLC decreased by 2% (97 +/- 1% to 95 +/- 1%, p<0.05). The peak Pesins/Pcapi decreased (0.79 +/- 0.10 to 0.57 +/- 0.05, p<0.05), and the Pcapi - Pesins increased (7.4 +/- 3 to 13.0 +/- 3 cm H2O, p<0.05). There was significant improvement in neuroventilatory coupling for volume change (Pesins/Pcapi/VT/TLC 5.45 +/- 0.5 to 3.25 +/- 1.0, p<0.05). There was a significant reduction in breathlessness as measured by Borg score (4.5 +/- 0.7 to 3.1 +/- 0.5, p<0.05) and there was a significant correlation between delta Borg and delta EILV/TLC (r=0.771, p<0.01) with a trend for Pesins/Pcapi/VT/TLC (r=0.544, p=0.067). There was also a significant correlation between delta EELV/TLC and delta Pesins/Pcapi/VT/TLC (r=0.772, p<0.01). The relationships between delta Borg, delta resting volumes, and flow rates were not significant. We conclude that in patients with COPD, inhaled bronchodilator reduces exercise DH and improves inspiratory pressure reserve and neuroventilatory coupling. Changes in DH and neuroventilatory coupling were the main determinants of reduced breathlessness.

This article has been cited by other articles:

				D. E. O'Donnell and K. A. Webb The major limitation to exercise performance in COPD is dynamic hyperinflation J Appl Physiol, August 1, 2008; 105(2): 753 - 755. [Full Text] [PDF]

				B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]

				C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD Chest, December 1, 2007; 132(6): 1778 - 1785. [Abstract] [Full Text] [PDF]

				J. A. Guenette, J. D. Witt, D. C. McKenzie, J. D. Road, and A. W. Sheel Respiratory mechanics during exercise in endurance-trained men and women J. Physiol., June 15, 2007; 581(3): 1309 - 1322. [Abstract] [Full Text] [PDF]

				D. J. Serisier, A. D. Coates, and S. D. Bowler Effect of Albuterol on Maximal Exercise Capacity in Cystic Fibrosis Chest, April 1, 2007; 131(4): 1181 - 1187. [Abstract] [Full Text] [PDF]

				A. F. Gelb, C. F. Taylor, P. A. McClean, C. M. Shinar, M. T. Rodrigues, C. A. Gutierrez, K. R. Chapman, and N. Zamel Tiotropium and Simplified Detection of Dynamic Hyperinflation Chest, March 1, 2007; 131(3): 690 - 695. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell and P. Laveneziana Lung hyperinflation in COPD: the impact of pharmacotherapy Eur. Respir. Rev., December 1, 2006; 15(100): 85 - 89. [Abstract] [Full Text] [PDF]

				E. F. M. Wouters Nonpharmacological modulation of dynamic hyperinflation Eur. Respir. Rev., December 1, 2006; 15(100): 90 - 96. [Abstract] [Full Text] [PDF]

				A. L. P. Albuquerque, L. E. Nery, D. S. Villaca, T. Y. S. Machado, C. C. Oliveira, A. T. Paes, and J. A. Neder Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III Eur. Respir. J., November 1, 2006; 28(5): 939 - 944. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell, F. Sciurba, B. Celli, D. A. Mahler, K. A. Webb, C. J. Kalberg, and K. Knobil Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD. Chest, September 1, 2006; 130(3): 647 - 656. [Abstract] [Full Text] [PDF]

				M. Kraft Asthma and chronic obstructive pulmonary disease exhibit common origins in any country! Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 238 - 240. [Full Text] [PDF]

				M M Peters, K A Webb, and D E O'Donnell Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD Thorax, July 1, 2006; 61(7): 559 - 567. [Abstract] [Full Text] [PDF]

				L. Nici, C. Donner, E. Wouters, R. Zuwallack, N. Ambrosino, J. Bourbeau, M. Carone, B. Celli, M. Engelen, B. Fahy, et al. American thoracic society/european respiratory society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1390 - 1413. [Full Text] [PDF]

				E. F. M. Wouters Approaches to Improving Health Status in Chronic Obstructive Pulmonary Disease: One or Several? Proceedings of the ATS, May 1, 2006; 3(3): 262 - 269. [Abstract] [Full Text] [PDF]

				P. W. Jones and A. G. N. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J., April 1, 2006; 27(4): 822 - 832. [Abstract] [Full Text] [PDF]

				B. R. Celli Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism. Proceedings of the ATS, January 1, 2006; 3(1): 58 - 65. [Abstract] [Full Text] [PDF]

				V Brusasco, R Hodder, M Miravitlles, L Korducki, L Towse, and S Kesten Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD Thorax, January 1, 2006; 58(5): 399 - 404. [Abstract] [Full Text] [PDF]

				A K McConnell In favour of respiratory muscle training Chronic Respiratory Disease, October 1, 2005; 2(4): 219 - 221. [PDF]

				W. Vincken Bronchodilator treatment of stable COPD: long-acting anticholinergics Eur. Respir. Rev., September 1, 2005; 14(94): 23 - 31. [Abstract] [Full Text] [PDF]

				F. Gigliotti, C. Coli, R. Bianchi, M. Grazzini, L. Stendardi, C. Castellani, and G. Scano Arm Exercise and Hyperinflation in Patients With COPD: Effect of Arm Training Chest, September 1, 2005; 128(3): 1225 - 1232. [Abstract] [Full Text] [PDF]

				I Vogiatzis, O Georgiadou, S Golemati, A Aliverti, E Kosmas, E Kastanakis, N Geladas, A Koutsoukou, S Nanas, S Zakynthinos, et al. Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease Thorax, September 1, 2005; 60(9): 723 - 729. [Abstract] [Full Text] [PDF]

				S. Nair, E. Thomas, S. B. Pearson, and M. T. Henry A Randomized Controlled Trial To Assess the Optimal Dose and Effect of Nebulized Albuterol in Acute Exacerbations of COPD Chest, July 1, 2005; 128(1): 48 - 54. [Abstract] [Full Text] [PDF]

				T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, and M. Mishima Exercise Capacity Deterioration in Patients With COPD: Longitudinal Evaluation Over 5 Years Chest, July 1, 2005; 128(1): 62 - 69. [Abstract] [Full Text] [PDF]

				N. S. Hopkinson, T. P. Toma, D. M. Hansell, P. Goldstraw, J. Moxham, D. M. Geddes, and M. I. Polkey Effect of Bronchoscopic Lung Volume Reduction on Dynamic Hyperinflation and Exercise in Emphysema Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 453 - 460. [Abstract] [Full Text] [PDF]

				G. Scano, L. Stendardi, and M. Grazzini Understanding dyspnoea by its language Eur. Respir. J., February 1, 2005; 25(2): 380 - 385. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley and N. G. Koulouris Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology Eur. Respir. J., January 1, 2005; 25(1): 186 - 199. [Abstract] [Full Text] [PDF]

				A. F. Gelb, C. A. Gutierrez, I. M. Weisman, R. Newsom, C. F. Taylor, and N. Zamel Simplified Detection of Dynamic Hyperinflation Chest, December 1, 2004; 126(6): 1855 - 1860. [Abstract] [Full Text] [PDF]

				P. W. Jones Clinical Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 167 - 170. [Abstract] [Full Text] [PDF]

				J R Hurst and J A Wedzicha Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation Postgrad. Med. J., September 1, 2004; 80(947): 497 - 505. [Abstract] [Full Text] [PDF]

				F. C. Sciurba Physiologic Similarities and Differences Between COPD and Asthma Chest, August 1, 2004; 126(2_suppl_1): 117S - 124S. [Abstract] [Full Text] [PDF]

				D.E. O'Donnell, N. Voduc, M. Fitzpatrick, and K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2004; 24(1): 86 - 94. [Abstract] [Full Text] [PDF]

				R Gosselink Breathing techniques in patients with chronic obstructive pulmonary disease (COPD) Chronic Respiratory Disease, July 1, 2004; 1(3): 163 - 172. [Abstract] [PDF]

				E. R. Sutherland and R. M. Cherniack Management of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 24, 2004; 350(26): 2689 - 2697. [Full Text] [PDF]

				B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur. Respir. J., June 1, 2004; 23(6): 932 - 946. [Full Text] [PDF]

				M. Pecchiari, A. Pelucchi, E. D'Angelo, A. Foresi, J. Milic-Emili, and E. D'Angelo Effect of Heliox Breathing on Dynamic Hyperinflation in COPD Patients Chest, June 1, 2004; 125(6): 2075 - 2082. [Abstract] [Full Text] [PDF]

				P M A Calverley Breathlessness during exercise in COPD: how do the drugs work? Thorax, June 1, 2004; 59(6): 455 - 457. [Full Text] [PDF]

				W D C Man, N Mustfa, D Nikoletou, S Kaul, N Hart, G F Rafferty, N Donaldson, M I Polkey, and J Moxham Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD Thorax, June 1, 2004; 59(6): 471 - 476. [Abstract] [Full Text] [PDF]

				J P Fuldl and M M Cotton Performance enhancement in chronic obstructive pulmonary disease Chronic Respiratory Disease, April 1, 2004; 1(2): 95 - 98. [Abstract] [PDF]

				V. A. De Palo Pulmonary Disease: Pneumonia, Chronic Obstructive Pulmonary Disease, Asthma, and Thromboembolic Disease J Am Podiatr Med Assoc, March 1, 2004; 94(2): 157 - 167. [Abstract] [Full Text] [PDF]

				B. Celli, R. ZuWallack, S. Wang, and S. Kesten Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes Chest, November 1, 2003; 124(5): 1743 - 1748. [Abstract] [Full Text] [PDF]

				S.I. Rennard and P. Calverley Rescue! Therapy and the paradox of the Barcalounger Eur. Respir. J., June 1, 2003; 21(6): 916 - 917. [Full Text] [PDF]

				T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, and M. Mishima A Comparison of the Effects of Salbutamol and Ipratropium Bromide on Exercise Endurance in Patients With COPD Chest, June 1, 2003; 123(6): 1810 - 1816. [Abstract] [Full Text] [PDF]

				P.W. Jones and R.M. Kaplan Methodological issues in evaluating measures of health as outcomes for COPD Eur. Respir. J., June 1, 2003; 21(41_suppl): 13S - 18s. [Abstract] [Full Text] [PDF]

				R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF]

				W MacNee and P M A Calverley Chronic obstructive pulmonary disease * 7: Management of COPD Thorax, March 1, 2003; 58(3): 261 - 265. [Abstract] [Full Text] [PDF]

				ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF]

				F. Di Marco, J. Milic-Emili, B. Boveri, P. Carlucci, P. Santus, F. Casanova, M. Cazzola, and S. Centanni Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Eur. Respir. J., January 1, 2003; 21(1): 86 - 94. [Abstract] [Full Text] [PDF]

				A. Corsico, P. Fulgoni, M. Beccaria, M. C. Zoia, G. Barisione, R. Pellegrino, V. Brusasco, and I. Cerveri Effects of exercise and beta 2-agonists on lung function in chronic obstructive pulmonary disease J Appl Physiol, December 1, 2002; 93(6): 2053 - 2058. [Abstract] [Full Text] [PDF]

				D. A. Mahler, P. Wire, D. Horstman, C.-N. Chang, J. Yates, T. Fischer, and T. Shah Effectiveness of Fluticasone Propionate and Salmeterol Combination Delivered via the Diskus Device in the Treatment of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2002; 166(8): 1084 - 1091. [Abstract] [Full Text] [PDF]

				E Boni, L Corda, D Franchini, P Chiroli, G P Damiani, L Pini, V Grassi, and C Tantucci Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax, June 1, 2002; 57(6): 528 - 532. [Abstract] [Full Text] [PDF]

				R. Aalbers, J. Ayres, V. Backer, M. Decramer, P.A. Lier, P. Magyar, J. Malolepszy, R. Ruffin, and G.W. Sybrecht Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial Eur. Respir. J., May 1, 2002; 19(5): 936 - 943. [Abstract] [Full Text] [PDF]

				M. I. Polkey Muscle Metabolism and Exercise Tolerance in COPD* Chest, May 1, 2002; 121(5_suppl): 131S - 135S. [Abstract] [Full Text] [PDF]

				M. F. Newton, D. E. O'Donnell, and L. Forkert Response of Lung Volumes to Inhaled Salbutamol in a Large Population of Patients With Severe Hyperinflation* Chest, April 1, 2002; 121(4): 1042 - 1050. [Abstract] [Full Text] [PDF]

				T. E. Dolmage and R. S. Goldstein Repeatability of Inspiratory Capacity During Incremental Exercise in Patients With Severe COPD Chest, March 1, 2002; 121(3): 708 - 714. [Abstract] [Full Text] [PDF]

				W. Vincken, J.A. van Noord, A.P.M. Greefhorst, Th.A. Bantje, S. Kesten, L. Korducki, and P.J.G. Cornelissen Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Eur. Respir. J., February 1, 2002; 19(2): 209 - 216. [Abstract] [Full Text] [PDF]

				R. Casaburi, D.A. Mahler, P.W. Jones, A. Wanner, G. San Pedro, R.L. ZuWallack, S.S. Menjoge, C.W. Serby, and T. Witek Jr A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2002; 19(2): 217 - 224. [Abstract] [Full Text] [PDF]

				D.E. O'Donnell, L. Forkert, and K.A. Webb Evaluation of bronchodilator responses in patients with "irreversible" emphysema Eur. Respir. J., December 1, 2001; 18(6): 914 - 920. [Abstract] [Full Text] [PDF]

				Managing stable chronic obstructive pulmonary disease DTB, November 1, 2001; 39(11): 81 - 85. [Abstract] [Full Text] [PDF]

				P W Jones Health status measurement in chronic obstructive pulmonary disease Thorax, November 1, 2001; 56(11): 880 - 887. [Abstract] [Full Text] [PDF]

				D. E. O'DONNELL, S. M. REVILL, and K. A. WEBB Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 770 - 777. [Abstract] [Full Text] [PDF]

				J Hadcroft and P M A Calverley Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease Thorax, September 1, 2001; 56(9): 713 - 720. [Abstract] [Full Text] [PDF]

				P.M.A. Calverley Modern treatment of chronic obstructive pulmonary disease Eur. Respir. J., July 2, 2001; 18(34_suppl): 60S - 66s. [Abstract] [Full Text] [PDF]

				M.L. Ayers, R. Mejia, J. Ward, T. Lentine, and D.A. Mahler Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD Eur. Respir. J., June 1, 2001; 17(6): 1132 - 1137. [Abstract] [Full Text] [PDF]

				J. M. MARIN, S. J. CARRIZO, M. GASCON, A. SANCHEZ, B. GALLEGO, and B. R. CELLI Inspiratory Capacity, Dynamic Hyperinflation, Breathlessness, and Exercise Performance during the 6-Minute-Walk Test in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1395 - 1399. [Abstract] [Full Text]

C. TAUBE, B. LEHNIGK, K. PAASCH, D. K. KIRSTEN, R. A. JÖRRES, and H. M